Rchr
J-GLOBAL ID：200901092307994933
Update date: Aug. 27, 2020
Takano Yasuo
タカノ ヤスオ | Takano Yasuo
Affiliation and department：
University of Toyama Faculty of Medicine, School of Medicine
About University of Toyama Faculty of Medicine, School of Medicine
Search "University of Toyama Faculty of Medicine, School of Medicine"
Detailed information
Research field (1)：
Human pathology
Research keywords (4)：
消化管腫瘍学
, 血液病理学
, gastroentero-oncology
, hematopathology
Research theme for competitive and other funds (4)：
悪性リンパ腫におけるsurvivin発現の検討
Epstin-Barr virus 陽性胃癌の発癌過程の解明
Aralysis on survivin overexpression in malignant lymphomas
Stndy on tumorigenesis of Epstein-Barr virus(+) gustric carcinomos
MISC (9)：
Y Takano, H Takenaka, Y Kato, M Masuda, T Mikami, M Saegusa, Okayasu, I. Cyclin D1 overexpression in invasive breast cancers: correlation with cyclin-dependent kinase 4 and oestrogen receptor overexpression, and lack of correlation with mitotic activity. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 1999. 125. 8-9. 505-512
The role of Epstein-Barr virus (EBV) in tumorigeneses of EBV(+) gastric carcinomas. Vershows Archiv. 1999. 17. 17-22
Yasuo Takano, Yo Kato, Mitsunobu Masuda, Yukihiko Ohshima, Isao Okayasu. Cyclin D2, but not cyclin D1, overexpression closely correlates with gastric cancer progression and prognosis. Journal of Pathology. 1999. 189. 2. 194-200
Y Yasogawa, Y Takano, Okayasu, I, A Kakita. The 5D4 antibody (anti-cyclin D1/D2) related antigen: Cytoplasmic staining is correlated to the progression of gastric cancer. PATHOLOGY INTERNATIONAL. 1998. 48. 9. 717-722
Y Takano, M Saegusa, M Masuda, T Mikami, Okayasu, I. Apoptosis, proliferative activity and Bcl-2 expression in Epstein-Barr-virus-positive non-Hodgkin's lymphomas. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY. 1997. 123. 7. 395-401
ｍore...
Professional career (1)：
(BLANK)
Association Membership(s) (3)：
日本リンパ網内系学会
, 日本癌学会
, 日本病理学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in
researchmap
.
For details, see here
.
Return to Previous Page
TOP
BOTTOM
